《2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》——冠状动脉疾病治疗:从归类走向精准
颜红兵,霍勇
摘要(Abstract)：
<正>为了反映近些年来对冠状动脉疾病病理生物学认识的重大进展,并将这些进展应用于临床,2019年8月31日在法国巴黎举行的欧洲心脏病学会(European Society of Cardiology,ESC)年会上发布了《2019年ESC慢性冠状动脉综合征诊断和管理指南》(以下简称《2019年指南》)[1],以替代《2013年稳定性冠状动脉疾病诊断和管理指南》(以下简称《2013年指南》)[2]。
关键词(KeyWords)： 冠状动脉疾病;冠状动脉综合征;指南解读
基金项目(Foundation):
作者(Author): 颜红兵,霍勇
参考文献(References)：
- [1] Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.Eur Heart J, 2019.[Epub ahead of print]
- [2] Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC Guidelines on the management of stable coronary artery disease:The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J, 2013, 34(38):2949-3003.
- [3] Ford TJ, Corcoran D, Berry C. Stable coronary syndromes:pathophysiology, diagnostic advances and therapeutic need. Heart,2018, 104(4):284-292.
- [4] Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:The task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for CardioThoracic Surgery(EACTS). Eur Heart J, 2018, 39(3):213-260.
- [5] Lüscher TF. Acute and chronic coronary syndromes:coronary dissection, intraplaque haemorrhage, and late lumen loss. Eur Heart J, 2018, 39(36):3339-3342.
- [6] Steg PG, Bhatt DL, Simon T, et al. Ticagrelor in patients with stable coronary disease and diabetes. N Engl J Med, 2019.[Epub ahead of print]
- [7] Bhatt DL, Steg PG, Mehta SR, et al. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention(THEMIS-PCI):a phase-3,placebo-controled, randomized trial. Lancet, 2019.[Epub ahead of print]